Organogenesis Holdings Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
3.07
0.17
(5.86%)
Volume:
206,302
52 week range:
1.96 - 4.71
Market Cap:
407.005M
Company Description:
Organogenesis Holdings Inc. develops, manufactures, and commercializes solutions for the advanced wound care, surgical and sports medicine markets in the United States. The company's products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved. NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; NuShield is a wound-covering tissue. NuCel is a dehydrated placental tissue surgically applied to the target tissue to support native healing. Nu